{"title":"以山茱萸化学成分变异和网络分析为指导的山茱萸酒制机理综合研究新策略。","authors":"Shilin Sun, Yuping Chen, Yu Zhang, Yukun Niu, Mengxin Yang, Xinming Jia, Yiqin Song, Qingwei Dong, Xin Qi, Jiahui Ma, Qian Zhang, Yiran Jin, Yingfeng Du","doi":"10.1186/s12906-025-05046-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Corni Fructus, a plant with both medicinal and edible properties, is renowned for its aromatic flavor and hepatoprotective and renoprotective effects, offering significant nutritional value and broad application potential. Wine-processed Corni Fructus (WCF) is a primary processed form of Corni Fructus, widely utilized in food supplements. Traditional Chinese medicine suggests that wine-processing enhances its hepatoprotective and renoprotective properties, yet the underlying mechanisms remain unclear.</p><p><strong>Objective: </strong>In this study, a novel comprehensive strategy guided by variation in the chemical components and differences in biological activities was developed to explore the wine-processing mechanisms.</p><p><strong>Materials and methods: </strong>Firstly, the chemical constituents in vitro and in vivo were identified by liquid chromatography coupled to high-resolution mass spectrometry liquid chromatography-mass spectrometry (LC-MS). Furthermore, chemometric analysis was applied to investigate the chemical characteristics in the samples with different processing methods. The possible molecular mechanism differences were unraveled by network pharmacology.</p><p><strong>Results: </strong>A total of 53 and 61 components were identified in vitro of crude Corni Fructus (CCF) and WCF, respectively. In addition, 39 and 43 components were detected in rats' serum after CCF and WCF administered by gavage. Ten common targets were identified as key targets for the therapeutic effects of CCF and WCF on Chronic kidney diseases (CKD). The network analysis showed that 23 components in WCF may be the active substances that make it more effective than CCF for treating CKD.</p><p><strong>Conclusions: </strong>This study provides a theoretical basis for the pharmacological substances of WCF and CCF and gives insights into comparing their pharmacological differences. It further investigates the mechanisms underlying different processing techniques of Corni Fructus, supporting further exploration of its potential in CKD management.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"25 1","pages":"312"},"PeriodicalIF":3.4000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12369163/pdf/","citationCount":"0","resultStr":"{\"title\":\"A novel comprehensive strategy for research on wine-processed mechanism of corni fructus guided by variation in the chemical components and network analysis.\",\"authors\":\"Shilin Sun, Yuping Chen, Yu Zhang, Yukun Niu, Mengxin Yang, Xinming Jia, Yiqin Song, Qingwei Dong, Xin Qi, Jiahui Ma, Qian Zhang, Yiran Jin, Yingfeng Du\",\"doi\":\"10.1186/s12906-025-05046-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Corni Fructus, a plant with both medicinal and edible properties, is renowned for its aromatic flavor and hepatoprotective and renoprotective effects, offering significant nutritional value and broad application potential. Wine-processed Corni Fructus (WCF) is a primary processed form of Corni Fructus, widely utilized in food supplements. Traditional Chinese medicine suggests that wine-processing enhances its hepatoprotective and renoprotective properties, yet the underlying mechanisms remain unclear.</p><p><strong>Objective: </strong>In this study, a novel comprehensive strategy guided by variation in the chemical components and differences in biological activities was developed to explore the wine-processing mechanisms.</p><p><strong>Materials and methods: </strong>Firstly, the chemical constituents in vitro and in vivo were identified by liquid chromatography coupled to high-resolution mass spectrometry liquid chromatography-mass spectrometry (LC-MS). Furthermore, chemometric analysis was applied to investigate the chemical characteristics in the samples with different processing methods. The possible molecular mechanism differences were unraveled by network pharmacology.</p><p><strong>Results: </strong>A total of 53 and 61 components were identified in vitro of crude Corni Fructus (CCF) and WCF, respectively. In addition, 39 and 43 components were detected in rats' serum after CCF and WCF administered by gavage. Ten common targets were identified as key targets for the therapeutic effects of CCF and WCF on Chronic kidney diseases (CKD). The network analysis showed that 23 components in WCF may be the active substances that make it more effective than CCF for treating CKD.</p><p><strong>Conclusions: </strong>This study provides a theoretical basis for the pharmacological substances of WCF and CCF and gives insights into comparing their pharmacological differences. It further investigates the mechanisms underlying different processing techniques of Corni Fructus, supporting further exploration of its potential in CKD management.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>\",\"PeriodicalId\":9128,\"journal\":{\"name\":\"BMC Complementary Medicine and Therapies\",\"volume\":\"25 1\",\"pages\":\"312\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12369163/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Complementary Medicine and Therapies\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12906-025-05046-y\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INTEGRATIVE & COMPLEMENTARY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Complementary Medicine and Therapies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12906-025-05046-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
A novel comprehensive strategy for research on wine-processed mechanism of corni fructus guided by variation in the chemical components and network analysis.
Background: Corni Fructus, a plant with both medicinal and edible properties, is renowned for its aromatic flavor and hepatoprotective and renoprotective effects, offering significant nutritional value and broad application potential. Wine-processed Corni Fructus (WCF) is a primary processed form of Corni Fructus, widely utilized in food supplements. Traditional Chinese medicine suggests that wine-processing enhances its hepatoprotective and renoprotective properties, yet the underlying mechanisms remain unclear.
Objective: In this study, a novel comprehensive strategy guided by variation in the chemical components and differences in biological activities was developed to explore the wine-processing mechanisms.
Materials and methods: Firstly, the chemical constituents in vitro and in vivo were identified by liquid chromatography coupled to high-resolution mass spectrometry liquid chromatography-mass spectrometry (LC-MS). Furthermore, chemometric analysis was applied to investigate the chemical characteristics in the samples with different processing methods. The possible molecular mechanism differences were unraveled by network pharmacology.
Results: A total of 53 and 61 components were identified in vitro of crude Corni Fructus (CCF) and WCF, respectively. In addition, 39 and 43 components were detected in rats' serum after CCF and WCF administered by gavage. Ten common targets were identified as key targets for the therapeutic effects of CCF and WCF on Chronic kidney diseases (CKD). The network analysis showed that 23 components in WCF may be the active substances that make it more effective than CCF for treating CKD.
Conclusions: This study provides a theoretical basis for the pharmacological substances of WCF and CCF and gives insights into comparing their pharmacological differences. It further investigates the mechanisms underlying different processing techniques of Corni Fructus, supporting further exploration of its potential in CKD management.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
